Phentermine
Phentermine is a pharmaceutical drug with 21 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 15 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
7
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.3%
15 of 18 finished
16.7%
3 ended early
2
trials recruiting
21
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery
Phentermine's Impact on Treatment in Teens
Anti-obesity Pharmacotherapy and Inflammation
Medications After Adolescent Bariatric Surgery
Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds
Clinical Trials (21)
Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery
Phentermine's Impact on Treatment in Teens
Anti-obesity Pharmacotherapy and Inflammation
Medications After Adolescent Bariatric Surgery
Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds
Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate
A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects
Individualized Obesity Pharmacotherapy
Phentermine/Gastric Band Weight Loss Study
Effect of Caloric Restriction on Fat Oxidation in Obese Men and Women (Magellan II)
Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery
Topiramate-Phentermine Combinations for Cocaine Dependence
Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant Users
Studying the Effects of Phentermine on Eating Behavior
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
The Effect of Phentermine and B12 on Weight Loss Among Obese Patients
A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults
A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects
Cardiovascular System in Obesity: Effect of Treatment
Study in Healthy Recreational Polydrug Users to Measure the Abuse Potential of TC-5214
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 21